GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Pretax Margin %

Ind-Swift Laboratories (NSE:INDSWFTLAB) Pretax Margin % : 8.41% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ind-Swift Laboratories's Pre-Tax Income for the three months ended in Dec. 2023 was ₹242 Mil. Ind-Swift Laboratories's Revenue for the three months ended in Dec. 2023 was ₹2,875 Mil. Therefore, Ind-Swift Laboratories's pretax margin for the quarter that ended in Dec. 2023 was 8.41%.

The historical rank and industry rank for Ind-Swift Laboratories's Pretax Margin % or its related term are showing as below:

NSE:INDSWFTLAB' s Pretax Margin % Range Over the Past 10 Years
Min: -21.7   Med: -0.67   Max: 9.29
Current: 9.29


NSE:INDSWFTLAB's Pretax Margin % is ranked better than
62.25% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.44 vs NSE:INDSWFTLAB: 9.29

Ind-Swift Laboratories Pretax Margin % Historical Data

The historical data trend for Ind-Swift Laboratories's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Pretax Margin % Chart

Ind-Swift Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.57 -2.54 2.02 1.21 7.17

Ind-Swift Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.79 5.30 10.19 13.38 8.41

Competitive Comparison of Ind-Swift Laboratories's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift Laboratories's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's Pretax Margin % falls into.



Ind-Swift Laboratories Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ind-Swift Laboratories's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=865.212/12073.1
=7.17 %

Ind-Swift Laboratories's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=241.94/2875.143
=8.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories  (NSE:INDSWFTLAB) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Ind-Swift Laboratories Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Traded in Other Exchanges
Address
SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101
Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines